KalVista Pharmaceuticals, Inc. (KALV)
19.30
+0.35
(+1.85%)
USD |
NASDAQ |
Mar 27, 16:00
19.30
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Shareholders Equity (Quarterly) : -2.711M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 671.39M |
| Recursion Pharmaceuticals, Inc. | 1.131B |
| Tango Therapeutics, Inc. | 346.18M |
| Modular Medical, Inc. | 5.881M |
| Iovance Biotherapeutics, Inc. | 698.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 335.38M |
| Total Liabilities (Quarterly) | 338.09M |
| Debt to Equity Ratio | -104.83 |
| Current Ratio | 5.582 |
| Net Debt Paydown Yield | -6.76% |